Myriad Genetics · 23 hours ago
VP Payer Strategy
Myriad Genetics is focused on improving patient access and reimbursement for their product portfolio. The VP Payer Strategy will be responsible for developing strategies for payer engagement, supporting product reimbursement efforts, and collaborating with marketing to enhance payer messaging.
BiotechnologyPharmaceuticalPrecision Medicine
Responsibilities
Identify and develop patient access strategy and research opportunities for US payers and key accounts ensuring alignment and inclusion of intended use
Deliver clinical, scientific, and health economic data to healthcare decision makers responsible for making medical policy and/or coverage decisions at health insurance companies, behavioral health companies, and/or employee benefit brokers
Collaborate with marketing to develop payer messaging and value proposition resources
Identify and communicate data gaps and work collaboratively with research teams to actively address evidence needs throughout product lifecycles. Providing strategic input into publication strategy
Provide medical leadership in the development of clinical utility evidence to support private and public payer reimbursement
Participate in development of payer reimbursement strategy across the portfolio of Myriad products
Support Revenue Cycle Department in payer discussions surrounding utilization management and the impact to patient access and clinical care
Identify and develop proposals for value-based contracting approaches with key payer stakeholders
Partner with Payer Markets Team to enhance the market position and reputation of Myriad within the physical and behavioral health insurance industry
Represent Myriad at the medical professional organization level, including key payer professional meetings
Qualification
Required
Bachelors Degree required
At least 10 years of experience in the health insurance industry
Ability to present and negotiate with executives at payer organizations
Extensive knowledge of the US healthcare ecosystem, payer landscape, and payer evidence requirements
Strong team player with excellent interpersonal skills and the ability to work cross-functionally throughout the company
Collaborative and strong leadership qualities; ability to build consensus
Demonstrated experience in clinical utility and outcomes-based research
Excellent strategic thinking skills, with demonstrated ability to successfully lead the ideation, development of a plan and move to action
Exceptional communicator, including both written and verbal skills, with ability to communicate on behalf of all company matters clearly and thoroughly
Preferred
Masters Degree preferred
Previous experience in precision medicine or diagnostic industry preferred
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Recent News
2025-12-24
Company data provided by crunchbase